TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response

Neuroscience Letters

Volumn 468, Issue 1, 2010, Pages 80-84

  Viikki, Merja ^a,b   Kampman, Olli ^a,c,d   Illi, Ari ^a   Setälä Soikkeli, Eija ^e   Anttila, Sami ^a,f   Huuhka, Martti ^f   Nuolivirta, Timo ^c   Poutanen, Outi ^f   Mononen, Nina ^f   Lehtimäki, Terho ^f   Leinonen, Esa ^a,f  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b Tampere Health Centre   (Finland)

^c SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^d Centre of Laboratory Medicine ^*  (Finland)

^e KANTA HÄME CENTRAL HOSPITAL   (Finland)

^f TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

ECT; Major depression; Polymorphism; TPH1; Treatment response

Indexed keywords

CITALOPRAM; FLUOXETINE; PAROXETINE; TRYPTOPHAN HYDROXYLASE; TRYPTOPHAN HYDROXYLASE 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; ELECTROCONVULSIVE THERAPY; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; REMISSION; RISK FACTOR; TREATMENT RESPONSE;

DEPRESSIVE DISORDER, MAJOR; DRUG RESISTANCE; ELECTROCONVULSIVE THERAPY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TRYPTOPHAN HYDROXYLASE;

EID: 70449529874     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.10.069     Document Type: Article

References (38)

1. Anttila S., Huuhka K., Huuhka M., Rontu R., Mattila K.M., Leinonen E., and Lehtimäki T. Interaction between TPH1 and GNB3 genotypes and electroconvulsive therapy in major depression. J. Neural Transm. 114 (2007) 461-468
2. Anttila S., Viikki M., Huuhka K., Huuhka M., Huhtala H., Rontu R., Lehtimäki T., and Leinonen E. TPH2 polymorphisms may modify clinical picture in treatment-resistant depression. Neurosci. Lett. 464 (2009) 43-46 (Epub August 11, 2009)
3. Bellevier F., Chaste P., and Malafosse A. Association between the TPH gene 218A/C polymorphism and suicidal behavior: a meta-analysis. Am. J. Med. Genet. 124B (2004) 87-91
4. Bellevier F., Leboyer M., Courtet P., Buresi C., Beaufils B., Samolyk D., Allilaire J.F., Feingold J., Mallet J., and Malafosse A. Association between the tryptophan hydroxylase gene and manic-depressive illness. Arch. Gen. Psychiatry 55 (1998) 33-37
5. Craig S.P., Boularand S., Darmon M.C., Mallet J., and Craig I.W. Localization of human tryptophan hydroxylase (TPH) to chromosome 11p15.3-p14 by in situ hybridization. Cytogenet. Cell Genet. 56 (1991) 157-159
6. Cusin C., Serretti A., Lattuada E., Lilli R., Lorenzi C., Mandelli L., Pisati E., and Smeraldi E. Influence of 5-HTTLPR and TPH variants on illness time course in mood disorders. J. Psychiatr. Res. 35 (2001) 217-223
7. Fava M., and Kendler K.S. Major depressive disorder. Neuron 28 (2000) 335-341
8. Frisch A., Postilnick D., Rockah R., Michaelovsky E., Postilnick S., Birman E., Laor N., Rauchverger B., Kreinin A., Poyurovsky M., Schneidman M., Modai I., and Weizman R. Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways. Mol. Psychiatry 4 (1999) 389-392
9. Furlong R.A., Ho L., Rubinsztein J.S., Walsh C., Paykel E.S., and Rubinsztein D.C. No association of the tryptophan hydroxylase gene with bipolar affective disorder, unipolar affective disorder, or suicidal behavior in major affective disorder. Am. J. Med. Genet. 81 (1998) 245-247
10. Gizatullin R., Zaboli G., Jönsson E.G., Åsberg M., and Leopardi R. Haplotype analysis reveals tryptophan hydroxylase (TPH) 1 gene variants associated with major depression. Biol. Psychiatry 59 (2006) 295-300
11. Ham B.J., Lee M.S., Lee H.J., Kang R.H., Han C.S., Choi M.J., Lee S.H., and Ryu S.H. No association between the tryptophan hydroxylase gene polymorphism and major depressive disorders and antidepressant response in a Korean population. Psychiatr. Genet. 15 (2005) 299-301
12. Ham B.J., Lee B.C., Paik J.W., Kang R.H., Choi M.J., Choi I.G., and Lee M.S. Association between the tryptophan hydroxylase-1 gene A218C polymorphism and citalopram antidepressant response in a Korean population. Prog. Neuropsychopharmacol. Biol. Psychiatry 31 (2007) 104-107
13. Huuhka K., Kampman O., Anttila S., Huuhka M., Rontu R., Mattila K.M., Hurme M., Lehtimäki T., and Leinonen E. RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder. Neurosci. Lett. 437 (2008) 25-28
14. Illi A., Setälä-Soikkeli E., Viikki M., Poutanen O., Huhtala H., Mononen N., Lehtimäki T., Leinonen E., and Kampman O. 5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression. Neuroreport 20 (2009) 1125-1128
15. Jönsson E.G., Goldman D., Spurlock G., Gustavsson J.P., Nielsen D.A., Linnoila M., Owen M.J., and Sedvall G.C. Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Eur. Arch. Psychiatry Clin. Neurosci. 247 (1997) 297-302
16. Kato M., Wakeno M., Okugawa G., Fukuda T., Azuma J., Kinoshita T., and Serretti A. No association of TPH1 218A/C polymorphism with treatment response and intolerance to SSRIs in Japanese patients with major depression. Neuropsychobiology 56 (2007) 167-171
17. Kunugi H., Ishida S., Kato T., Sakai T., Tatsumi M., Hirose T., and Nanko S. No evidence for an association of polymorphisms of the tryptophan hydroxylase gene with affective disorders or attempted suicide among Japanese patients. Am. J. Psychiatry 156 (1999) 774-776
18. Lalovic A., and Turecki G. Meta-analysis of the association between tryptophan hydroxylase and suicidal behavior. Am. J. Med. Genet. 114 (2002) 533-540
19. Mann J.J., Malone K.M., Nielsen D.A., Goldman D., Erdos J., and Gelernter J. Possible association of a polymorphism of the tryptophan hydroxylase gene with suicidal behavior in depressed patients. Am. J. Psychiatry 154 (1997) 1451-1453
20. Martínez A., Knappskog P.M., and Haavik J. A structural approach into human tryptophan hydroxylase and its implications for the regulation of serotonin biosynthesis. Curr. Med. Chem. 8 (2001) 1077-1091
21. Montgomery S.A., and Åsberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134 (1979) 382-389
22. Nakamura K., and Hasegawa H. Developmental role of tryptophan hydroxylase in the nervous system. Mol. Neurobiol. 35 (2007) 45-54
23. Nielsen D.A., Jenkins G.L., Stefanisko K.M., Jefferson K.K., and Goldman D. Sequence, splice site and population frequency distribution analyses of the polymorphic human tryptophan hydroxylase intron 7. Brain Res. Mol. Brain Res. 45 (1997) 145-148
24. Nielsen D.A., Virkkunen M., Lappalainen J., Eggert M., Brown G.L., Long J.C., Goldman D., and Linnoila M. A tryptophan hydroxylase gene marker for suicidality and alcoholism. Arch. Gen. Psychiatry 55 (1998) 593-602
25. Peters E.J., Slager S.L., Jenkins G.D., Reinalda M.S., Garriock H.A., Shyn S.I., Kraft J.B., McGrath P.J., Knowles J.A., and Hamilton S.P. Resequencing of serontoni-related genes and association of tagging SNPs to citalopram response. Pharmocogenet. Genom. 19 (2009) 1-10
26. Peters E.J., Slager S.L., McGrath P.J., Knowles J.A., and Hamilton S.P. Investigation of serotonin-related genes in antidepressant response. Mol. Psychiatry 9 (2004) 879-889
27. Roy A., Rylander G., Forslund K., Åsberg M., Mazzanti C.M., Goldman D., and Nielsen D.A. Excess tryptophan hydroxylase 17 779C allele in surviving cotwins of monozygotic twin suicide victims. Neuropsychobiology 43 (2001) 233-236
28. Saetre P., Lundmark P., Hansen T., Rasmussen H.B., Djurovic S., Melle I., Andreassen O.A., Werge T., Agartz I., Hall H., Terenius L., and Jönsson E.G. The tryptophan hydroxylase 1 (TPH1) gene, schizophrenia susceptibility, and suicidal behavior: a multi-centre case-control study and meta-analysis. Am. J. Med. Genet. B: Neuropsychiatr. Genet. (2009) (Epub ahead of print)
29. Serretti A., Christina S., Lilli R., Cusin C., Lattuada E., Lorenzi C., Corradi B., Grieco G., Costa A., Santorelli F., Barale F., Nappi G., and Smeraldi E. Family-based association study of 5-HTTLPR, TPH, MAO-A, and DRD4 polymorphisms in mood disorders. Am. J. Med. Genet. 114 (2002) 361-369
30. Serretti A., Lilli R., Lorenzi C., Lattuada E., Cusin C., and Smeraldi E. Tryptophan hydroxylase gene and major psychosis. Psychiatry Res. 103 (2001) 79-86
31. Serretti A., Zanardi R., Cusin C., Rossini D., Lorenzi C., and Smeraldi E. Tryptophan hydroxylase gene associated with paroxetine antidepressant activity. Eur. Neuropsychopharmacol. 11 (2001) 375-380
32. Serretti A., Zanardi R., Rossini D., Cusin C., Lilli R., and Smeraldi E. Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity. Mol. Psychiatry 6 (2001) 586-592
33. Tsuang M.T., and Faraone S.V. The Genetics of Mood Disorders (1990), The Johns Hopkins University Press, Baltimore pp. 1-31
34. Van Praag H.M. 5-HT-related, anxiety- and/or aggression-driven depression. Int. Clin. Psychopharmacol. 9 (1994) 5-6
35. Yoshida K., Naito S., Takahashi H., Sato K., Ito K., Kamata M., Higuchi H., Shimizu T., Itoh K., Inoue K., Tezuka T., Suzuki T., Ohkubo T., Sugawara K., and Otani K. Monoamine oxidase gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder. Prog. Neuropsychpharmacol. Biol. Psychiatry 26 (2002) 1279-1283
36. Zaboli G., Jönsson E.G., Gizatullin R., Åsberg M., and Leopardi R. Tryptophan hydroxylase-1 gene variants associated with schizophrenia. Biol. Psychiatry 60 (2006) 563-569
37. Zhang X., Beaulieu J.M., Sotnikova T.D., Gainetdinov R.R., and Caron M.G. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 305 (2004) 217
38. Zill P., Büttner A., Eisenmenger W., Möller H.J., Ackenheil M., and Bondy B. Analysis of tryptophan hydroxylase I and II mRNA expression in the human brain: a post-mortem study. J. Psychiatr. Res. 41 (2007) 168-173